Astellas Pharma | 4503 - Operating Expenses

Stock Price
2,247.50
Daily Change
24.50 1.10%
Monthly
5.52%
Yearly
57.44%
Q1 Forecast
2,057.60

Astellas Pharma reported JPY419.91B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Astellas Pharma JPY 419.91B 6.66B Sep/2025
Chugai Pharma JPY 177.3B 604M Dec/2025
Daiichi Sankyo JPY 468.57B 15.34B Dec/2025
Eisai JPY 183.69B 1.78B Sep/2025
Kyowa Hakko Kirin JPY 92.94B 20.17B Sep/2025
M3 JPY 69.01B 1.54B Sep/2025
Otsuka Holdings JPY 469.16B 21.76B Sep/2025
Shionogi JPY 73.75B 240M Dec/2025
Sumitomo Dainippon JPY 43.46B 43.51B Sep/2025
Takeda JPY 1.02T 400.98B Dec/2025
Terumo JPY 229.87B 25.79B Sep/2025